Which management strategy should be recommended for this patient's bone health? (poll 6465786)

Which management strategy should be recommended for this patient's bone health?

Begin calcium & vitamin D supplementation and obtain baseline bone mineral density

Begin calcium & vitamin D supplementation and initiate IV bisphosphonate

Begin calcium & vitamin D supplementation and initiate subcutaneous denosumab

Begin calcium & vitamin D supplementation and initiate oral bisphosphonate

Vote View Results

See this poll on: https://poll.fm/6465786/embed

An oncology nurse - 12 years ago

Why wouldn't the answer be initiate calcium, vit D, get DEXA, AND start on subQ denosumab since aromatase inhibitors can cause a significant decrease in BMD within the first year of therapy? Research has shown calcium and vit D isn't enough to prevent the BMD decrease and therefore the fracture risk when patients are on AI's